- Home
- GLOB vs LMRI Comparison
GLOB vs LMRI Comparison
Compare GLOB & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLOB | LMRI |
|---|---|---|
| Founded | 2003 | 2018 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2015 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GLOB | LMRI |
|---|---|---|
| Price | $46.60 | $11.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 10 |
| Target Price | ★ $52.00 | $17.67 |
| AVG Volume (30 Days) | ★ 855.5K | 297.0K |
| Earning Date | 11-12-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.26 |
| Revenue Next Year | $1.96 | $5.41 |
| P/E Ratio | ★ $22.55 | $233.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.56 | $6.45 |
| 52 Week High | $72.10 | $19.45 |
Technical Indicators
Market Signals| Indicator | GLOB | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 71.41 | 56.02 |
| Support Level | $41.92 | $11.10 |
| Resistance Level | $48.17 | $11.79 |
| Average True Range (ATR) | 2.08 | 0.45 |
| MACD | 0.54 | 0.11 |
| Stochastic Oscillator | 98.58 | 60.61 |
Price Performance
Historical ComparisonAbout GLOB Globant S.A.
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.
About LMRI Lumexa Imaging Holdings Inc. Common Stock
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.